We are live on
!
Find out more
KC
Kepos Capital Portfolio holdings
AUM
$61.3M
1-Year Est. Return
12.13%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+12.13%
3 Year Est. Return
+22.16%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$985M
AUM Growth
-$349M
(-26%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-13.64%
Top 10 Holdings %
Top 10 Hldgs %
44.05%
Holding
450
New
115
Increased
26
Reduced
96
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$236M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$45.2M |
| 3 |
Liberty Broadband Class C
LBRDK
|
+$22.3M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$19.6M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$55.6M |
| 2 |
CELG
Celgene Corp
CELG
|
+$37.5M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$22.8M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$16.1M |
| 5 |
Centene
CNC
|
+$14.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.36% |
| 2 | Consumer Discretionary | 7.88% |
| 3 | Financials | 7.38% |
| 4 | Healthcare | 7.21% |
| 5 | Industrials | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Idexx Laboratories
IDXX
$42.9B
| $2.94M | 0.3% |
+10,681
| New | +$2.63M |
|
52
Intuit
INTU
$81.1B
| $2.94M | 0.3% |
+11,250
| New | +$2.86M |
|
53
Innoviva
INVA
$1.58B
| $2.92M | 0.3% |
200,669
-54,118
| -21% | -$767K |
|
|
XLNX
54
DELISTED
Xilinx Inc
XLNX
| $2.92M | 0.3% |
24,745
-28,182
| -53% | -$3.29M |
|
55
Neurocrine Biosciences
NBIX
$17.7B
| $2.92M | 0.3% |
34,545
-19,794
| -36% | -$1.63M |
|
|
THCBU
56
DELISTED
Tuscan Holdings Corp. Unit
THCBU
| $2.89M | 0.29% |
272,500
-1,160,000
| -81% | -$12.2M |
|
57
EnerSys
ENS
$6.95B
| $2.87M | 0.29% |
41,876
-24,373
| -37% | -$1.59M |
|
58
MGM Resorts International
MGM
$11.7B
| $2.86M | 0.29% |
100,000
| – | – |
|
59
Chipotle Mexican Grill
CMG
$40.8B
| $2.85M | 0.29% |
+194,800
| New | +$2.75M |
|
|
GHDX
60
DELISTED
Genomic Health, Inc.
GHDX
| $2.84M | 0.29% |
48,893
-8,507
| -15% | -$504K |
|
61
Incyte
INCY
$23.5B
| $2.81M | 0.29% |
+33,086
| New | +$2.66M |
|
62
Evercore
EVR
$13.1B
| $2.81M | 0.29% |
31,718
+20,661
| +187% | +$1.84M |
|
|
AMED
63
DELISTED
Amedisys
AMED
| $2.8M | 0.28% |
+23,091
| New | +$2.74M |
|
64
Cadence Design Systems
CDNS
$90B
| $2.8M | 0.28% |
+39,544
| New | +$2.64M |
|
65
MSCI
MSCI
$40B
| $2.77M | 0.28% |
+11,609
| New | +$2.6M |
|
66
AbbVie
ABBV
$458B
| $2.77M | 0.28% |
38,052
-43,880
| -54% | -$3.45M |
|
67
Molina Healthcare
MOH
$10.3B
| $2.77M | 0.28% |
19,320
-8,191
| -30% | -$1.12M |
|
68
VeriSign
VRSN
$25.3B
| $2.76M | 0.28% |
+13,213
| New | +$2.59M |
|
|
CALY
69
Callaway Golf Company
CALY
$3.26B
| $2.76M | 0.28% |
160,996
-1
| -0% | -$17 |
|
70
Autodesk
ADSK
$44.3B
| $2.74M | 0.28% |
16,834
-18,178
| -52% | -$3.06M |
|
71
Mastercard
MA
$477B
| $2.73M | 0.28% |
10,319
-15,485
| -60% | -$3.88M |
|
72
LendingTree
TREE
$544M
| $2.72M | 0.28% |
+6,481
| New | +$2.48M |
|
|
ALXN
73
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.72M | 0.28% |
20,749
-26,064
| -56% | -$3.36M |
|
74
PPG Industries
PPG
$25.9B
| $2.71M | 0.28% |
+23,204
| New | +$2.65M |
|
75
Edwards Lifesciences
EW
$47.6B
| $2.69M | 0.27% |
+43,605
| New | +$2.64M |
|
Similar funds
HPCM
CP
TCM
TCDRS
ACM
BGPJL
CMANY
AC
Kepos Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Kepos Capital held 450 positions worth $985M, down 26% from $1.33B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Kepos Capital withdrew a net $134M in Q2 2019, closing 147 positions and reducing 96 holdings. Its most notable exit was Altaba Inc, an estimated $55.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Kepos Capital opened a new position in Mellanox Technologies, Ltd. worth $19.2M.
- Kepos Capital's largest Q2 2019 buy was Mellanox Technologies, Ltd.: 2,051,667 shares worth $19.2M.
- Kepos Capital added most to State Street Consumer Staples Select Sector SPDR ETF in Q2 2019, an estimated $45.2M increase.
- Kepos Capital's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $37.5M.
- Kepos Capital fully exited Altaba Inc in Q2 2019, selling an estimated $55.6M.
- Kepos Capital's ten largest holdings make up 44% of its $985M portfolio in Q2 2019.
- Kepos Capital opened 115 new positions and closed 147 in Q2 2019.
- Kepos Capital's portfolio value fell 26% quarter-over-quarter to $985M.
Based on Kepos Capital's 13F filing for Q2 2019, filed 13 Aug 2019.